Skip to content
Search

Latest Stories

Defect information notice issued for Ibuprofen tablets of Aspar

The Medicines and Health products Regulatory Agency (MHRA) has issued a class four medicines defect information notice for Ibuprofen 200mg and 400mg tablets of Aspar Pharmaceuticals.

The patient information leaflets (PILs) within the ibuprofen packs are missing some information which should be documented in section three and section four of the PIL, Aspar Pharmaceuticals Limited has said.


How to take the tablets (section three)

Current information in the PILCorrect information that should be included in the PIL
Seek medical attention IMMEDIATELY if you accidentally take too many tablets.Seek medical attention IMMEDIATELY if you accidentally take too many tablets. If you have taken more than you should, or if children have taken this medicine by accident always contact a doctor or nearest hospital to get an opinion of the risk and advice on action to be taken. The symptoms can include nausea, stomach pain, vomiting (may be blood-streaked), headache, ringing in the ears, confusion and shaky eye movement. At high doses, drowsiness, chest pain, palpitations, loss of consciousness, convulsions (mainly in children), weakness and dizziness, blood in urine, cold body feeling, and breathing problems have been reported.

Possible side effects (section four)

Current information in the PILCorrect information that should be included in the PIL
(No appropriate wording related to DRESS syndrome)A severe skin reaction known as DRESS syndrome can occur. Symptoms of DRESS include: skin rash, fever, swelling of lymph nodes and an increase of eosinophils (a type of white blood cells).

Product Description

MDR number of the product is MDR 054-07/20 and ibuprofen is the active pharmaceutical ingredient.
ProductPack SizePL Number
Aspar Ibuprofen 200mg Caplets (GSL)16PL 08977/0015
ProductPack SizePL Number
Nisa Ibuprofen Tablets BP 200mg (GSL)16PL 08977/0016
Lloyds Pharmacy Ibuprofen 200mg Tablets (GSL)16PL 08977/0016
Lloyds Pharmacy Ibuprofen200mg Tablets (P)24, 48, 16PL 08977/0016
Lifestyle Ibuprofen Tablets BP 200mg (GSL)16PL 08977/0016
Ibucalm 200mg Tablets (GSL)16PL 08977/0016
Ibucalm 200mg Tablets (P)24, 48, 16PL 08977/0016
Careway Ibuprofen 200mg Tablets (GSL)16PL 08977/0016
Careway Ibuprofen 200mg Tablets (P)25, 48PL 08977/0016
Asda Ibuprofen 200mg Tablets (P)48PL 08977/0016
ProductPack Size(s)PL Number
Ibucalm 400mg Tablets (P)24, 48, 96PL 08977/0017
Asda Ibuprofen 400mg Tablets (P)48, 96PL 08977/0017
Careway Ibuprofen 400mg Tablets (P)24, 48PL 08977/0017
Lloyds Pharmacy Ibuprofen 400mg Tablets (P)12, 24, 48, 96PL 08977/0017

Advice for healthcare professionals

Community pharmacists have been adviced that if any of the above products are supplied or dispensed, then they should ensure that patients are aware of the missing information as mentioned above.

It is important that any patients who notice any symptoms following the use of the product should seek immediate medical advice.

The patients who experience side effects from taking any medicines should be encouraged to report a suspected problem or incident via the Yellow Card scheme and seek medical advice accordingly.

More For You

Antibiotic prescribing for sore throats in England's pharmacies is twice as high as in Wales

Antibiotic supply rate was 72.7% under England’s Acute Sore Throat Pharmacy First compared to just 29.9% under Wales’ Sore Throat Test and Treat (STTT) scheme in six months.

Getty Images

Sore throat treatment: England pharmacies twice as likely to prescribe antibiotics as Welsh counterparts

A new study has highlighted significant differences in antibiotic use for sore throat treatment between pharmacies in England and Wales, suggesting that incorporating throat swabs to confirm bacterial infections could help reduce “unnecessary antibiotic supply.”

The study, published in the Journal of Antimicrobial Chemotherapy and first reported by The Independent, found that pharmacies in England were twice as likely to prescribe antibiotics for sore throats compared to those in Wales.

Keep ReadingShow less
GPs to play crucial role in transforming Wales’ health service

Jeremy Miles

(Photo credit: www.gov.wales )

Strengthening GPs’ role key to transforming healthcare - Jeremy Miles

Welsh health secretary Jeremy Miles has recognised the need to transform health services and bring healthcare closer to home.

Speaking at the recent Welsh Local Medical Committees Conference, he emphasised that strengthening the role of GPs would be crucial in improving patient healthcare and tackling NHS waiting lists.

Keep ReadingShow less
NPA and IPA urge NHS England to release pharmacy economic analysis immediately

Pharmacy bodies call for transparency on the funding gap amid ongoing contract negotiations.

Getty Images

Pharmacy bodies demand immediate release of economic analysis

The National Pharmacy Association (NPA) and the Independent Pharmacies Association (IPA) have jointly written to NHS England, demanding the immediate release of the independent economic analysis of pharmacy finances commissioned last autumn.

An open letter, signed by the owners of 3,034 pharmacies in England, calls for transparency on the funding gap amid ongoing contract negotiations.

Keep ReadingShow less
Discrimination: Asian and Black patients report lack of trust in primary care providers

Ethnic minority groups had worse experiences in their communication with their GP practice and felt taken less seriously

Getty Images

Survey reveals alarming rates of ethnic discrimination in NHS primary care

A recent survey by the NHS Race and Health Observatory has highlighted a worrying lack of trust in NHS primary care services among Black, Asian, and ethnic minority patients, who reported experiencing “racial or ethnic discrimination.”

Out of 2,680 survey respondents, only 55% reported trusting primary care providers to meet their health needs most or all of the time

Keep ReadingShow less